This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEG7N134_L.jpgIn the new phase, the age range has been expanded, with adults between 60 and 84 years accounting for nearly 50% of the trial’s population.
Early-stage data from a small clinical trial of the vaccine has shown it produced high levels of virus-fighting antibodies, and the company aims to begin larger studies to obtain regulatory approvals as early as December.